Latest Helicos Biosciences Corporation (HLCSQ) Hea
Post# of 3
Posted On: 03/10/2014 3:29:21 AM
Latest Helicos Biosciences Corporation (HLCSQ) Headlines
BG Medicine, Inc. Appoints Stephen P. Hall as Chief Financial Officer
GlobeNewswire - Thu Nov 14, 7:30AM CST
BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3 Test, announced today that its Board of Directors has appointed Stephen P. Hall, as the company's Executive Vice President, Chief Financial Officer.
Global Next Generation Sequencing Market 2012-2016 with Life Technologies Corp., Roche Holding AG, and Pacific Biosciences of California Inc. Dominating
M2 - Fri Oct 11, 11:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mcn3b3/global_next) has announced the addition of the "Global Next Generation Sequencing Market 2012-2016" report to their offering. The analysts forecast the Global Next Generation Sequencing market to grow at a CAGR of 20.78 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased adoption of next generation sequencing by new customers. The Global Next Generation Sequencing market has also been witnessing an introduction of new DNA sequencing products and accessories. However, the logistical problems could pose a challenge to the growth of this market. The key vendors dominating this market space are Illumina Inc., Life Technologies Corp., Roche Holding AG, and Pacific Biosciences of California Inc. The other vendors mentioned in the report are 23andMe Inc., Ambry Genetics Corp., Axeq Technologies Inc., Beijing Genomics Institute, GeneDx, Fluidigm Corp., Foundation Medicine Inc., Good Start Genetics Inc., Helicos BioSciences Corp., Knome Inc., NABsys Inc., Oxford Nanopore Technologies Ltd., Pathogenica Inc., QIAGEN N.V, RainDance Technologies Inc., Sequenom Inc., Takara Bio Inc. Commenting on the report, an analyst from the team said: With the expansion of the customer base to less sophisticated customers, access to improved bioinformatics tools is becoming even more of a priority. Sequencing companies started to seriously tackle this issue: in 2012 Life Technologies unveiled Ion Reporter, a commercial cloud-based variant analysis software package and purchased Compendia Bioscience. Illumina launched BaseSpace Apps, a dedicated application store for BaseSpace, its genomics cloud computing platform. In addition, Illumina secured the buy-in of bioinformatics companies such as Golden Helix, Biomatters, Ingenuity, Station X, and Spiral Genetics, on top of collaborations with Diagnomics, Ingenuity, and Knome. According to the report, the growth of the Global Next-generation Sequencing market is driven by several factors, the most important of which is the increased adoption of next-generation sequencing technology by new customers. For more information visit http://www.researchandmarkets.com/research/mc...lobal_next About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
BG Medicine, Inc. Appoints Stephen P. Hall as Chief Financial Officer
GlobeNewswire - Thu Nov 14, 7:30AM CST
BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3 Test, announced today that its Board of Directors has appointed Stephen P. Hall, as the company's Executive Vice President, Chief Financial Officer.
Global Next Generation Sequencing Market 2012-2016 with Life Technologies Corp., Roche Holding AG, and Pacific Biosciences of California Inc. Dominating
M2 - Fri Oct 11, 11:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mcn3b3/global_next) has announced the addition of the "Global Next Generation Sequencing Market 2012-2016" report to their offering. The analysts forecast the Global Next Generation Sequencing market to grow at a CAGR of 20.78 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased adoption of next generation sequencing by new customers. The Global Next Generation Sequencing market has also been witnessing an introduction of new DNA sequencing products and accessories. However, the logistical problems could pose a challenge to the growth of this market. The key vendors dominating this market space are Illumina Inc., Life Technologies Corp., Roche Holding AG, and Pacific Biosciences of California Inc. The other vendors mentioned in the report are 23andMe Inc., Ambry Genetics Corp., Axeq Technologies Inc., Beijing Genomics Institute, GeneDx, Fluidigm Corp., Foundation Medicine Inc., Good Start Genetics Inc., Helicos BioSciences Corp., Knome Inc., NABsys Inc., Oxford Nanopore Technologies Ltd., Pathogenica Inc., QIAGEN N.V, RainDance Technologies Inc., Sequenom Inc., Takara Bio Inc. Commenting on the report, an analyst from the team said: With the expansion of the customer base to less sophisticated customers, access to improved bioinformatics tools is becoming even more of a priority. Sequencing companies started to seriously tackle this issue: in 2012 Life Technologies unveiled Ion Reporter, a commercial cloud-based variant analysis software package and purchased Compendia Bioscience. Illumina launched BaseSpace Apps, a dedicated application store for BaseSpace, its genomics cloud computing platform. In addition, Illumina secured the buy-in of bioinformatics companies such as Golden Helix, Biomatters, Ingenuity, Station X, and Spiral Genetics, on top of collaborations with Diagnomics, Ingenuity, and Knome. According to the report, the growth of the Global Next-generation Sequencing market is driven by several factors, the most important of which is the increased adoption of next-generation sequencing technology by new customers. For more information visit http://www.researchandmarkets.com/research/mc...lobal_next About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
(0)
(0)Helicos Biosciences Corporation (HLCSQ) Stock Research Links
Scroll down for more posts ▼